The DURABLE trial study design: comparing the safety, efficacy, and durability of insulin glargine to insulin lispro mix 75/25 added to oral antihyperglycemic agents in patients with type 2 diabetes.
about
The DURAbility of Basal versus Lispro mix 75/25 insulin Efficacy (DURABLE) trial: comparing the durability of lispro mix 75/25 and glargineUnderstanding heterogeneity in response to antidiabetes treatment: a post hoc analysis using SIDES, a subgroup identification algorithm.DURAbility of basal versus lispro mix 75/25 insulin efficacy (DURABLE) trial 24-week results: safety and efficacy of insulin lispro mix 75/25 versus insulin glargine added to oral antihyperglycemic drugs in patients with type 2 diabetes.Ethnic differences in glycemic markers in patients with type 2 diabetes.Durability of glycemic control with insulin lispro mix 75/25 versus insulin glargine for older patients with type 2 diabetes.Initiating insulin therapy in elderly patients with Type 2 diabetes: efficacy and safety of lispro mix 25 vs. basal insulin combined with oral glucose-lowering agents.
P2860
The DURABLE trial study design: comparing the safety, efficacy, and durability of insulin glargine to insulin lispro mix 75/25 added to oral antihyperglycemic agents in patients with type 2 diabetes.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The DURABLE trial study design ...... patients with type 2 diabetes.
@en
The DURABLE trial study design ...... patients with type 2 diabetes.
@nl
type
label
The DURABLE trial study design ...... patients with type 2 diabetes.
@en
The DURABLE trial study design ...... patients with type 2 diabetes.
@nl
prefLabel
The DURABLE trial study design ...... patients with type 2 diabetes.
@en
The DURABLE trial study design ...... patients with type 2 diabetes.
@nl
P2093
P2860
P1476
The DURABLE trial study design ...... patients with type 2 diabetes.
@en
P2093
Honghua Jiang
Jessie Fahrbach
Scott Jacober
Sherry Martin
P2860
P304
P356
10.1177/193229680800200514
P577
2008-09-01T00:00:00Z